[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345783-105":59,"doc-detail-345783-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","synergistic-probe-combining-lysosome-anchoring-and-tumor-defense-system-targeting-for-precise-tumor-visualization","Synergistic Probe Combining Lysosome Anchoring and Tumor Defense System Targeting for Precise Tumor Visualization","","Precise tumor imaging is essential for accurate intraoperative decision-making, directly affecting patient prognosis. Optical molecular probes enable non-invasive, dynamic assessment of cancer lesions, yet existing optical probes struggle to simultaneously avoid false-positive and false-negative signals, limiting clinical diagnostic reliability. A lysosome-targeted, activatable optical probe class leverages lysosomal abundance during tumor metabolic reprogramming to improve retention and reduce false negatives. A redesigned γ-glutamyltransferase-activated probe produces distinct fluorescence and photoacoustic responses for multi-modal imaging with high specificity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/synergistic-probe-combining-lysosome-anchoring-and-tumor-defense-system-targeting-for-precise-tumor-visualization/345783/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/synergistic-probe-combining-lysosome-anchoring-and-tumor-defense-system-targeting-for-precise-tumor-visualization/345783.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is precise tumor imaging critical for clinical outcomes?","Question",{"text":113,"@type":114},"Precise tumor imaging supports accurate intraoperative decision-making, which directly influences patient prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What key problem do current optical molecular probes face?",{"text":118,"@type":114},"They must avoid false-positive and false-negative signals simultaneously, which current probes do not do reliably enough for clinical use.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the proposed lysosome-targeted activatable probe improve imaging performance?",{"text":122,"@type":114},"It leverages increased lysosomal abundance in tumor metabolic reprogramming for better intracellular retention and fewer false-negative signals, and it produces strong fluorescence and photoacoustic changes upon activation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345783,1790192817,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Advanced Science  \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nSynergistic Probe Combining Lysosome Anchoring and Tumor Defense System Targeting for Precise Tumor Visualization  \nYang Shen1, 2  Jiawei Li2  Ruixi Yi2  Ling Shi2  Wei Li2, 3  Sulai Liu1   Lin Yuan2   \n1 Department of Hepatobiliary Surgery, Central Laboratory, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, P. R. China  2 State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha, P. R.  \nChina  3 School of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing, P. R. China Correspondence: Sulai Liu ([liusulai@hunnu.edu.cn](liusulai@hunnu.edu.cn))  \nReceived: 21 January 2026  Revised: 9 April 2026  Accepted: 27 April 2026  \nKeywords: activatable fluorescent probe | high-precision imaging | lysosome | molecular imaging | tumor imaging  \nABSTRACT  \nPrecise tumor imaging is essential for accurate intraoperative decision-making, thereby directly influencing patient prognosis. Optical molecular probes enabling non-invasive, dynamic assessment of cancerous lesions are clinically crucial. However, current optical molecular probes face challenges in dodging false-positive and false-negative signals at once during imaging, limiting their clinical diagnostic use. Here, we introduce a class of lysosome-targeted, activatable optical probes (Dx-NH2 ), leveraging the increased lysosomal abundance during tumor metabolic reprogramming. Lysosomal protonation retains probes for better singlecell resolution and fewer false-negative signals. To enable more high-precision tumor imaging, we synthesized probe CN-D-GGT from CN-D-NH2 by introducing a γ-glutamyltransferase substrate, following our group’s prior offensive and defensive integration strategy. Due to its smart design, CN-D-GGT, upon activation, shows marked changes in fluorescence and photoacoustic signals, enabling its application for multi-modal imaging. It also has high specificity, distinguishing cancer cells in co-culture (∼6-fold) and clearly differentiating tumors from normal and inflamed tissues (T/N or T/I signal ratios > 3.5). Importantly, it can also differentiate cancerous from adjacent tissues in clinical samples. This work has developed a probe that can accurately light tumors in complex pathological environments, with the potential to assist in intraoperative resection decision-making, avoid excessive or missed resection.  \n1  Introduction  \nAs one of the most lethal global health burdens, cancer requires high-precision diagnostic tools to assist clinical operations, aiming to simultaneously reduce recurrence rates and enhance patient quality of life [1] . Optical molecular probes have been used in the clinical diagnosis of cancer by taking advantage of their non-invasiveness, high sensitivity, and high selectivity [2– 6]. However, the current repertoire of optical molecular probes for precise tumor imaging remains limited. Two major challenges are  \noff-target activation, which produces false-positive signals, and post-activation diffusion of the fluorophore, which can result in false-negative imaging outcomes.  \nTo reduce nonspecific probe activation, the researchers developed a dual-lock molecular design strategy that incorporates multiple tumor microenvironment biomarkers, thereby markedly improving imaging specificity and the signal-to-noise ratio in tumor imaging [7, 8] . However, a fundamental limitation of these probes lies in the diffusion of the activated fluorophore  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH  \nAdvanced Science, 2026; 0:e75664 1 of 10  \n[https://doi.org/10.1002/advs.75664](https://doi.org/10.1002/adv","cbCaihSA1iPnT8yA","https://ap.wps.com/l/cbCaihSA1iPnT8yA","pdf",7967722,"English","# Abstract\n# Introduction","[{\"question\":\"Why is precise tumor imaging critical for clinical outcomes?\",\"answer\":\"Precise tumor imaging supports accurate intraoperative decision-making, which directly influences patient prognosis.\"},{\"question\":\"What key problem do current optical molecular probes face?\",\"answer\":\"They must avoid false-positive and false-negative signals simultaneously, which current probes do not do reliably enough for clinical use.\"},{\"question\":\"How does the proposed lysosome-targeted activatable probe improve imaging performance?\",\"answer\":\"It leverages increased lysosomal abundance in tumor metabolic reprogramming for better intracellular retention and fewer false-negative signals, and it produces strong fluorescence and photoacoustic changes upon activation.\"}]","Synergistic Probe Combining Lysosome Anchoring and Tumor Defense System Targeting for Precise Tumor Visualization | PDF",1790058862,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/550f7c9c9e658f3b29705714ab204939.webp",983,1283,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8660b217863119ef8088b03a4d3a616b.webp",982,1281,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db0aff14328bf9df8d3fa83934550532.webp",981,1280,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34d61bfe48b791be5a0375c8ea74e7bb.webp",980,1279]